A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies

The vast majority of patients with plasma cell neoplasms die of progressive disease despite high response rates to novel agents. Malignant plasma cells are very radiosensitive, but the potential role of radioimmunotherapy (RIT) in the management of plasmacytomas and multiple myeloma (MM) has undergo...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Green, Damian J., Orgun, Nural N., Jones, Jon C., Hylarides, Mark D., Pagel, John M., Hamlin, Donald K., Wilbur, D.S., Lin, Yukang, Fisher, Darrell R., Kenoyer, Aimee L., Frayo, Shani L., Gopal, Ajay K., Orozco, Johnnie J., Gooley, Theodore A., Wood, Brent L., Bensinger, William I., Press, Oliver W.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3970848/
https://ncbi.nlm.nih.gov/pubmed/24371230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-1589
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky